Please login to the form below

Taflinar

This page shows the latest Taflinar news and features for those working in and with pharma, biotech and healthcare.

BMS gets two new cancer approvals in Europe

all patents regardless of their BRAF status, potentially making it more useful than BRAF inhibitors such as Roche's Zelboraf (vemurafenib) and Novartis' Taflinar (dabrafenib).

Latest news

BMS bags US approval for Opdivo and Yervoy combo

inhibitors such as Roche's Zelboraf (vemurafenib) and GSK's Taflinar (dabrafenib).
NICE backs GSK’s Tafinlar for skin cancer

NICE said the information provided by GSK suggested that Taflinar works as well as Zelboraf, which also targets the BRAF V600 mutations.
NICE fast-tracks GSK's skin cancer drug Tafinlar

However, just as Roche was forced to discount Zelboraf's price before NICE recommended it, the new Taflinar guidance was only issued on the basis GSK discount its drug's list ... Taflinar was approved in Europe in August 2013, based on phase III results
GSK's personalised cancer drug Tafinlar set for European approval

Regulatory advisors recommend the melanoma drug be licensed

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Account Director, Healthcare Advertising Agency: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Sudler London - Account Director: Competitive

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Medical Writer - Creative and Scientific Projects: DOE

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Writer, Healthcare Advertising, London: Excellent package

Systematic Review Lead- London: Negotiable

Market Access Consultant - Greater Manchester: Negotiable

Associate Scientific Director: Salary TBC

Account Director or Senior Account Director: Salary TBC

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior Account Manager – Healthcare Advertising: Salary TBC

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Medical Writer: Salary is DOE

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Graduate Scientific Editor: DOE

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Subscribe to our email news alerts

PMHub

Add my company

Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....